Clinical Practice Guideline: Inflammatory Breast Cancer
Brief Description: Inflammatory Breast Cancer (IBC) is a rare subset of aggressive invasive breast cancer that presents rapidly (< 6 months) through erythema and/or edema of a third or more of the skin of the breast. Pathologically, tumor cells are often present in the dermal lymphatics of the involved skin. However, dermal lymphatic involvement is neither required, nor sufficient on its own for a diagnosis. To document a diagnosis, providers should use IHIS staging tool (cT4d). Practitioners should consider ordering an URGENT consult/referral to the Spielman breast center IBC Team if/when a patient presents with symptoms concerning for IBC (e.g., rapid erythema and/or edema of a third or more of the skin of the breast).